Skip to main content
Livermore
Livermore
ZHEN

Skorpios Trust

SEC CIK
0001869333
Latest filing
Oct 29, 2025

STOK holding history

Stoke Therapeutics, Inc. in every 13F filed by Skorpios Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

STOK overviewAll 13F holders of STOKFull Q3 2025 holdings

Shares (Q3 2025)
2,256,181
Value
$53.0M
% of portfolio
99.7%
Quarters held
16
Since Q4 2021
Holdings of STOK by Skorpios Trust, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20252,256,181$53.0M99.7%−1,000,000−30.7%ReducedHolders
Q2 20253,256,181$37.0M99.6%−3,650,000−52.9%ReducedHolders
Q1 20256,906,181$45.9M99.7%00.0%UnchangedHolders
Q4 20246,906,181$76.2M99.8%−2,000,000−22.5%ReducedHolders
Q3 20248,906,181$109.5M99.8%−1,937,500−17.9%ReducedHolders
Q2 202410,843,681$146.5M99.9%−3,600,000−24.9%ReducedHolders
Q1 202414,443,681$195.0M99.9%00.0%UnchangedHolders
Q4 202314,443,681$76.0M99.8%00.0%UnchangedHolders
Q3 202314,443,681$56.9M99.8%00.0%UnchangedHolders
Q2 202314,443,681$153.5M66.7%00.0%UnchangedHolders
Q1 202314,443,681$120.3M48.6%00.0%UnchangedHolders
Q4 202214,443,681$133.3M42.4%00.0%UnchangedHolders
Q3 202214,443,681$185.5M52.3%00.0%UnchangedHolders
Q2 202214,443,681$190.8M79.8%00.0%UnchangedHolders
Q1 202214,443,681$304.0M81.0%00.0%UnchangedHolders
Q4 202114,443,681$346.5M76.7%–No prior filingHolders